Latest Updates

The Swiss company, Actelion, alleged that the Indian drugmakers proposed generic Bosentan 32 mg will infringe upon its patent and…

The company reported a sustained growth in India formulations (up 10 per cent YoY) to Rs 3.5bn, while branded formulation exports…

The Development Operations Centre supports the development of AstraZeneca’s innovative medicines and hosts clinical trial experts…

The conference will convene over 130 data management and biostatistics subject matter experts and leaders across pharma, biotech,…

The company said it has reached a settlement agreement with Onyx Therapeutics related to generic versions of 10 mg, 30 mg and 60…

The EBIDTA reported by the company stood at Rs 28.5 crores, while the Profit after Tax (PAT) stood at Rs 11.6 crore for Q4FY19

Under the program, subject matter experts from Biocon and M S Ramaiah College’s faculty will impart real world insights and hands…

Consolidated net profit rises 6.62 per cent to Rs 1,616.62 million for Q4 FY 2018-19

'Lupin Sahayak' is a new patient's awareness initiative byLupin’s Synox Team, that focuses on diabetes and hypertension

The plant had undergone a routine shutdown for repairs and maintenance along with a de-bottlenecking programme for capacity…